NSAIDS, gastrointestinal injury, and cytoprotection

Gastroenterology Clinics of North America

Volumn 25, Issue 2, 1996, Pages 279-298

  Scheiman, J M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; HISTAMINE H2 RECEPTOR ANTAGONIST; MISOPROSTOL; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN SYNTHASE; PROTON PUMP INHIBITOR;

CELL PROTECTION; DEATH; DIGESTIVE SYSTEM INJURY; DIGESTIVE SYSTEM ULCER; GASTROINTESTINAL MUCOSA; HEALTH CARE COST; HOSPITALIZATION; HUMAN; REVIEW; RHEUMATOID ARTHRITIS; STOMACH EPITHELIUM; UNITED KINGDOM; UNITED STATES;

EID: 0030013358     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8553(05)70247-8     Document Type: Article

References (93)

1. N.M. Agrawal S. Roth D.Y. Graham Misoprostol compared with sucralfate in the prevention of nonsteroidal anti-inflammatory drug-induced gastric ulcer: A randomized, controlled trial Ann Intern Med 115 1991 195 200
2. M.C. Allison A.G. Howatson C.J. Torrance Gastrointestinal damage associated with the use of nonsteroidal anti-inflammatory drugs N Engl J Med 327 1992 749 754
3. C.P. Armstrong A.L. Blower Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration Gut 28 1987 527 532
4. I. Barrison Prophylaxis against non-steroidal induced upper gastrointestinal side effects Ann Rheum Dis 50 1991 207 209
5. D.N. Bateman NSAID's: Time to re-evaluate gut toxicity Lancet 343 1994 1051 1052
6. K.R. Bhaskar P. Garik B.S. Turner Viscous fingering of HCl through gastric mucin Nature 360 1992 458 461
7. I. Bjarnson J. Hayllar A.J. Macpherson Side effects of nonsteroidal antiinflammatory drugs on the small and large intestine in humans Gastroenterology 104 1993 1832 1847
8. I. Bjarnason J. Hayllar P. Smethurst Metronidazole reduces intestinal inflammation and blood loss in non-steroidal anti-inflammatory drug induced enteropathy Gut 33 1992 1204 1208
9. J.D. Bradley K.D. Brandt B.P. Katz Comparison of an antiinflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee N Engl J Med 325 1991 87 91
10. J.L. Carson B.L. Strom M.L. Morse The relative gastrointestinal toxicity of the nonsteroidal anti-inflammatory drugs Arch Intern Med 147 1987 1054 1059
11. H.O. Conn Y. Poynard Corticosteroids and peptic ulcer: Meta-analysis of adverse events during steroid therapy J Intern Med 236 1994 619 632
12. B. Cryer M. Goldschmiedt J.S. Redfern Comparison of salsalate and aspirin on mucosal injury and gastroduodenal mucosal prostaglandins Gastroenterology 99 1990 1616 1621
13. B. Cryer G. Luk M. Feldman Effects of very low doses of aspirin (asa) on gastric, duodenal and rectal prostaglandins and mucosal injury Gastroenterol 108 1995 A77
14. P. Dandona J.Y. Jeremy Nonsteroidal anti-inflammatory drug therapy and gastric side effects: Does nabumetone provide a solution? Drugs 40 suppl 5 1990 16 24
15. T.K. Daneshmend A.G. Stein N.K. Bhaskar Abolition by omeprazole of aspirin-induced gastric mucosal injury in man Gut 31 1990 514 519
16. J.T. Edelson A.N.A. Tosteson P. Sax Cost-effectiveness of misoprostol for prophylaxis against nonsteroidal anti-inflammatory drug-induced gastrointestinal tract bleeding JAMA 264 1990 41 47
17. R.S.B. Ehsanullah M.C. Page G. Tildesley Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: Controlled trial of ranitidine BMJ 297 1988 1017 1021
18. P. Ekstrom L. Carling S. Wetterhus Omeprazole reduces the frequency of gastroduodenal lesions and dyspeptic symptoms during NSAID treatment Gastroenterology 108 1995 A87
19. S.L. Elliott N.D. Yeomans R.R.C. Buchanan Efficacy of 12 months' misoprostol as prophylaxis against NSAID-induced gastric ulcers Scand J Rheumatol 23 1994 171 176
20. L.L. Estes D.W. Fuhs A.H. Heaton Gastric ulcer perforation associated with the use of injectable ketorolac Ann Pharmacother 27 1993 42 43
21. W. Feil S. Klimesch P. Karner Importance of an alkaline microenvironment for rapid restitution of the rabbit duodenal mucosa in vitro Gastroenterology 97 1989 112 122
22. M. Feldman T.J. Colturi Effect of indomethacin on gastric acid and bicarbonate secretion in humans Gastroenterology 87 1984 1339 1343
23. 3—transport: Characteristics and proposed role in acidity regulation and mucosal protection Am J Physiol 242 1982 G183 G193
24. J.F. Fries NSAID gastropathy: The second most deadly rheumatic disease? Epidemiology and risk appraisal J Rheumatol 18 suppl 28 1991 6 10
25. S.E. Gabriel L. Jaakkimainen C. Bombardie Risk for serious gastrointestinal complications related to use of NSAIDS: A meta-analysis Ann Int Med 115 1991 787 796
26. G.R. Gibson E.B. Whitacre C.A. Ricotti Colitis induced by nonsteroidal anti-inflammatory drugs Arch Intern Med 152 1992 625 632
27. D.Y. Graham N.M. Agrawal S.H. Roth Prevention of NSAID-induced gastric ulcer with misoprostol: Multicenter, double-blind, placebo-controlled trial Lancet 2 1988 1277 1280
28. D.Y. Graham M.D. Lidsky A.M. Cox Long-term nonsteroidal antiinflammatory drug use and Helicobacter pylori infection Gastroenterology 100 1991 1653 1657
29. D.Y. Graham J.L. Smith H.J. Spjut Gastric adaptation: Studies in humans during continuous aspirin administration Gastroenterology 95 1988 327 333
30. D.Y. Graham R.H. White L.W. Moreland Duodenal and gastric ulcer prevention with misoprostol in arthritis patients taking NSAIDs Ann Intern Med 119 1993 257 262
31. C.J. Hawkey Non-steroidal anti-inflammatory drugs and peptic ulcers BMJ 300 1990 278 284
32. D. Henry A. Dobson C. Turner Variability in the risk of major gastrointestinal complications from nonaspirin, nonsteroidal anti-inflammatory drugs Gastroenterology 105 1993 1078 1088
33. S. Holt V. Rigoglioso M. Sidhu Nonsteroidal antiinflammatory drugs and lower gastrointestinal bleeding Dig Dis Sci 38 1993 1619 1623
34. N. Hudson A.S. Taha R.I. Russell High dose famotidine as healing and maintenance treatment for non-steroidal anti-inflammatory drug-associated gastroduodenal ulceration Gastroenterology 108 1995 A117
35. 3 co-transport Am J Physiol 265 1993 677 685
36. J.G. Kim D.Y. Graham Misoprostol Study Group Helicobacter pylori infection and development of gastric or duodenal ulcer in arthritic patients receiving chronic NSAID therapy Am J Gastroenterol 89 1994 203 206
37. T. Kitahora P.H. Guth Effect of aspirin plus hydrochloric acid on the gastric mucosal microcirculation Gastroenterology 93 1987 810 817
38. J.H. Kurata D.E. Abbey The effect of chronic aspirin use on duodenal and gastric ulcer hospitalizations J Clin Gastroenterol 12 1990 260 266
39. K. Kusterrer K.H. Buchheit A. Schade The somatostatin analogue octreotide protects against ehtanol-induced microcirculatory stasis and elevated vascular permeability in rat gastric mucose Eur J Pharmacol 259 1994 265
40. E.R. Lacy Epithelial restitution in the gastrointestinal tract J Clin Gastroenterol 10 1988 72 77
41. E.R. Lacy S. Ito Microscopic analysis of ethanol damage to rat gastric mucosa after treatment with a prostaglandin Gastroenterology 83 1982 619 625
42. A. Lanas M.C. Sekar B.I. Hirschowitz Objective evidence of aspirin use in both ulcer and nonulcer upper and lower gastrointestinal bleeding Gastroenterology 103 1992 862 951
43. O. Laneuville D.K. Breuer D.L. DeWitt Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by nonsteroidal anti-inflammatory drugs Journal of Pharmacology and Experimental Therapeutics 271 1994 927 939
44. F.L. Lanza G.L. Royer Jr R.S. Nelson Endoscopic evaluation of the effects of aspirin, buffered aspirin, and enteric-coated aspirin on gastrin and duodenal mucosa N Engl J Med 303 1980 136 138
45. S. Levi R.A. Goodlad C.Y. Lee Inhibitory effect of non-steroidal anti-inflammatory drugs on mucosal cell proliferation associated with gastric ulcer healing Lancet 2 1990 840 843
46. L.R. Levine M.L. Cloud N.H. Enas Nizatidine prevents peptic ulceration in high-risk patients taking nonsteroidal anti-inflammatory drugs Arch Intern Med 153 1993 2449 2454
47. L.M. Lichtenberger Z. Wang J.J. Romero Nonsteroidal anti-inflammatory drugs (NSAIDs) associate with zwitterionic phospholipids: Insight into the mechanism and reversal of NSAID-induced gastrointestinal injury Nature Med 1 1995 154 158
48. D.S. Loeb N.J. Talley D.A. Ahlquist Long-term nonsteroidal anti-inflammatory drug use and gastroduodenal injury: The role of Helicobacter pylori Gastroenterology 102 1992 1899 1905
49. T.M. MacDonald S.V. Morant G.C. Robinson The risk of serious upper GI complications is constant with continuous NSAID therapy: Results of a second linkage study in 52,383 exposed patients Gastroenterology 108 1995 A156
50. D.M. McCarthy Nonsteroidal antiinflammatory drug induced ulcers: Management by traditional therapies Gastroenterology 96 1989 662 674
51. T.A. Miller Gastroduodenal mucosal defense: Factors responsible for the ability of the stomach and duodenum to resist injury Surgery 103 1988 389 397
52. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease: Helicobacter pylori in peptic ulcer disease JAMA 272 1994 65 69
53. H.E. Paulus FDS Arthritis Advisory Committee meeting: Postmarketing surveillance of nonsteroidal antiinflammatory drugs Arthritis Rheum 28 1985 1168 1169
54. J.M. Piper W.A. Ray J.R. Daugherty Corticosteroid use and peptic ulcer disease: Role of nonsteroidal anti-inflammatory drugs Ann Intern Med 114 1991 735 740
55. J.S. Redfern M. Feldman Role of endogenous prostaglandins in preventing gastrointestinal ulceration: Induction of ulcers by antibodies to prostaglandins Gastroenterology 96 1989 596 605
56. A. Robert J.E. Nezamis C. Lancaster Cytoprotection by prostaglandin in rats: Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCI and thermal injury Gastroenterology 77 1979 433 443
57. L.A.G. Rodriguez H. Jick Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs Lancet 343 1994 769 772
58. S. Roth N. Agrawal M. Mahowald Misoprostol heals gastroduodenal injury in patients with rheumatoid arthritis receiving aspirin Arch Intern Med 149 1989 775 779
59. S. Roth R. Bennett P. Caldron Reduced risk of NSAID gastropathy (GI mucosal toxicity) with nonacetylated salicylate (salsalate): An endoscopic study Semin Arthritis Rheum 19 suppl 2 1990 11 20
60. H.E. Rugstad K.E. Giersky G. Husby Effect of cimetidine on gastrointestinal symptoms in patients taking nonsteroidal anti-inflammatory drugs Scand J Rheumatol 23 1994 177 182
61. + back-diffusion Nature 313 1985 52 54
62. J. Sarosiek K. Mizuta A. Slomiany Effects of acetylsalicylic acid on gastric mucin viscosity, permeability to hydrogen ion, and susceptibility to pepsin Biochem Pharmacol 35 1986 4291 4295
63. J.M. Scheiman Pathogenesis of gastroduodenal injury due to nonsteroidal antiinflammatory drugs: Implications for prevention and therapy Semin Arthritis Rheum 21 1992 201 210
64. J.M. Scheiman E.M. Behler R.R. Berardi Salicylsalicylic acid causes less gastroduodenal mucosal damage than enteric-coated aspirin an endoscopic comparison Dig Dis Sci 34 1989 229 232
65. J.M. Scheiman E.M. Behler I. Crause Mucosa protection from NSAID-induced injury by low dose octreotide in humans Gastroenterology 108 1995 A212
66. J.M. Scheiman E.M. Behler K.L. Loeffler Omeprazole ameliorates aspirin-induced gastroduodenal injury Dig Dis Sci 39 1994 97 103
67. J.M. Scheiman G.H. Elta Gastroduodenal mucosal damage with salsalate versus aspirin: Results of experimental models and endoscopic studies in humans Semin Arthritis Rheum 20 1990 121 127
68. 2-induced secretion of surfactant phospholipid by isolated gastric mucous cells Gastroenterology 100 1991 1232 1240
69. R.T. Schoen R.J. Vender Mechanisms of nonsteroidal anti-inflammatory drug-induced gastric damage Am J Med 86 1989 449 458
70. 2 output in human subjects Ann Intern Med 106 1987 368 371
71. R.I. Shorr W.A. Ray J.R. Daugherty Concurrent use of nonsteroidal anti-inflammatory drugs and oral anticoagulants places elderly persons at high risk for hemorrhagic peptic ulcer disease Arch Intern Med 153 1993 1665 1670
72. 3 and mucosal restitution J Intern Med 228 1990 59 62
73. F.S. Silverstein G.S. Geis B.J. Struthers NSAIDs and gastrointestinal injury: Clinical outcome, the MUCOSA trial Gastroenterology 106 1994 A180
74. A.H. Soll W.M. Weinstein J. Kurata Nonsteroidal anti-inflammatory drugs and peptic ulcer disease Ann Intern Med 114 1991 307 319
75. H. Sorbye K. Svanes The role of blood flow in gastric mucosal defence, damage and healing Dig Dis 12 1994 305 317
76. C. Stamm E. Burkhalter W. Pearce Benign colonic ulcers associated with nonsteroidal antiinflammatory drug ingestion Am J Gastroenterol 89 1994 2230 2233
77. G. Stucki M. Johannesson M. Liang Is misoprostol cost-effective in the prevention of nonsteroidal anti-inflammatory drug-induced gastropathy in patients with chronic arthritis? Arch Intern Med 154 1994 2020 2025
78. A.S. Taha S. Dahill R.D. Sturrock Predicting NSAID related ulcers—assessment of clinical and pathological risk factors and importance of differences in NSAID Gut 35 1994 891 895
79. A.S. Taha N. Hudson P. Trye Prevention of NSAID-related gastric and duodenal ulcers by famotidine: A placebo-controlled double-blind study Gastroenterology 106 1994 A190
80. A.S. Taha S. McLaughlin P.J. Holland Effect on gastric and duodenal mucosal prostaglandins of repeated intake of therapeutic doses of naproxen and etodolac in rheumatoid arthritis Ann Rheum Dis 49 1990 354 358
81. A.S. Taha R.I. Russell Helicobacter pylori and non-steroidal anti-inflammatory drugs: Uncomfortable partners in peptic ulcer disease Gut 34 1993 580 583
82. S.D. Taylor H.C. Soudah W.Y. Chey Prostaglandins mediate the inhibition of human gastric acid secretion produced by intraduodenal acidification and secretin but not intraduodenal fat Gastroenterology 107 1994 1680 1685
83. J.R. Vane J.A. Mitchell I. Appelton Inducible isoforms of cyclooxygenase and nitric oxide synthase in inflammation Proc Natl Acad Sci USA 91 1994 2046 2050
84. A. Walan J.P. Bader M. Classen Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer N Engl J Med 320 1989 69 75
85. J.L. Wallace Mechanisms of nonsteroidal anti-inflammatory drug (NSAID) induced gastrointestinal damage—potential for development of gastrointestinal tract safe NSAIDs Can J Physiol Pharmacol 72 1994 1493 1498
86. J.L. Wallace K.E. Arfors G.W. McKnight A monoclonal antibody against the CD18 leukocyte adhesion molecule prevents indomethacin-induced gastric damage in the rabbit Gastroenterology 100 1991 878 883
87. J.L. Wallace C.M. Keenan M. Cucala Mechanisms underlying the protective effects of interleukin 1 in experimental nonsteroidal anti-inflammatory drug gastropathy Gastroenterology 102 1992 1176 1175
88. J.L. Wallace C.M. Keenan D.N. Granger Gastric ulceration induced by nonsteroidal antiinflammatory drugs in a neutrophil-dependent process Am J Physiol 259 1990 G462 G467
89. J.L. Wallace G.W. McKnight The mucoid cap over superficial gastric dmage in the rat: A high-pH microenvironment dissipated by nonsteroidal anti-inflammatory drugs and endothelin Gastroenterology 99 1990 295 304
90. J.L. Wallace B. Reuter C. Cicala A diclofenac derivative without ulcerogenic properties Eur J Pharmacol 257 1994 249 255
91. J.L. Wallace B. Reuter C. Cicala Novel nonsterodial anti-inflammatory drug derivatives with markedly reduced ulcerogenic properties in the rat Gastroenterology 107 1994 173 179
92. R.P. Walt Misoprostol for the treatment of peptic ulcer and antiinflammatory drug induced gastroduodenal ulceration N Engl J Med 327 1992 1575 1580
93. J. Weil D. Colin Jones M.J.S. Langman Prophylactic aspirin and peptic ulcer bleeding Gastroenterology 108 1995 A256